Post renal-transplant malignancy surveillance

Area of Science:

• Nephrology
• Oncology
• Immunology

Background:

• Kidney transplant recipients exhibit elevated cancer incidence versus the general population.
• Malignancy is a leading cause of mortality in transplant patients, second only to cardiovascular disease.
• Immunosuppression significantly contributes to increased cancer risk by impairing immune surveillance and viral oncogenesis control.

Purpose of the Study:

• To review the epidemiology and risk factors of malignancy in kidney transplant recipients.
• To discuss the challenges and current debates surrounding cancer screening in this cohort.
• To present screening guidelines for specific cancers prevalent in post-transplant patients.

Main Methods:

• Review of existing literature on post-transplant malignancy.
• Analysis of epidemiological data and risk factors.
• Synthesis of current screening recommendations and challenges.

Main Results:

• Transplant recipients have a higher risk of developing various cancers.
• Cancer-related mortality rates are elevated in solid organ transplant recipients.
• Evidence for routine cancer screening in this population is limited, necessitating careful consideration.

Conclusions:

• Kidney transplant recipients require vigilant monitoring for malignancy due to increased risk.
• Personalized cancer screening strategies are essential, balancing early detection benefits against potential harms.
• Further research, including randomized controlled trials, is needed to establish definitive screening protocols.